Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats

• Published in: The American journal of physiology Vol. 266; no. 1 Pt 2; p. R228
• Main Authors: Malpas, S C, Coote, J H
• Format: Journal Article
• Language: English
• Published: United States 01.01.1994
• Subjects: Animals; Electric Stimulation; Electrophysiology; Glutamates - pharmacology; Glutamic Acid; Homocysteine - analogs & derivatives; Homocysteine - pharmacology; Injections, Spinal; Male; Paraventricular Hypothalamic Nucleus - physiology; Rats; Rats, Wistar; Sympathetic Nervous System - physiology; Vasopressins - antagonists & inhibitors; Vasopressins - pharmacology; Vasopressins - physiology
• ISSN: 0002-9513
• DOI: 10.1152/ajpregu.1994.266.1.R228

Vasopressin may play an extrahypothalamic role in the central control of the cardiovascular system, specifically acting as a spinal neurotransmitter in the pathway where the paraventricular nucleus (PVN) alters sympathetic outflow. In this study, the effect of stimulating neuronal cell bodies in the PVN on renal sympathetic nerve activity (RSNA) and the possible involvement of vasopressin in the pathway was investigated in anesthetized rats. The PVN was stimulated by microinjection with 0.2 M D,L-homocysteic acid via a glass micropipette, and the hemodynamic and sympathetic responses were recorded. A computerized sympathetic peak-detection algorithm was applied to recordings of sympathetic discharges to retrieve information about the characteristics of RSNA during PVN stimulation. The algorithm scanned the series of RSNA voltages for significant increases followed by significant decreases in a small cluster of voltage values. Once each synchronized RSNA peak had been detected, its corresponding amplitude and peak-to-peak interval were calculated. PVN stimulation consistently increased the amplitude of RSNA (mean 30 +/- 5.6% over control), arterial pressure, and the peak-to-peak interval of discharges. A V1 vasopressin antagonist intrathecally administered as a 500-pmol dose was subsequently able to completely block the hemodynamic response (blood pressure increase of 14 +/- 5%) and a 35 +/- 6% increase in RSNA in response to PVN stimulation and intrathecal vasopressin. Thus spinal vasopressin is likely to be a neurotransmitter involved in the cardiovascular regulation involving the PVN.